510(k) · Cleared
ClearedCareside PT
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Careside, Inc. · GJS Test, Time, Prothrombin
Cleared on Jul 26, 1999 as substantially equivalent to K974343 (Dade Intl., Inc., 1998) and 1 other predicate after a 117-day review. Its family tree reaches back 2 generations to 1989.
- Decided
- Jul 26, 1999
- Review
- 117 days
- Class
- Class II
- Product code
- GJS
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 2 generations to K891169 (1989). 3 ancestors in all, the oldest K884863 (1989). No later device cites it as a predicate yet.
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K891169 | Dade Thromboplastin IS | Baxter Healthcare Corp | 1989 | — |
| −1 | K974343 | Dade Innovin | Dade Intl., Inc. | 1998 | — |
| 0 (this device) | K991065 | Careside PT | Careside, Inc. | 1999 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1989 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GJS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GJS device
- #1 K243543 microINR Systemscore 13.4 · 6 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K974343 | Dade InnovinSummary page 1…he quantitative measurement of prothrombin time on the MLA Electra 900C. Name of Predicate Device: Dade Innovin on the MLA Electra 900C. Predicate Device S10K number: K974343 (Innovin)/K884863~(Electra 900C) Product Code: 81GIJS (Innovin)/81GKP (Electra 900C) CARESIDE, Inc. CARESIDE™ PT… | 1998 |
| * | K884863 | Electra 900C Automatic Coagulation TimerSummary page 1…asurement of prothrombin time on the MLA Electra 900C. Name of Predicate Device: Dade Innovin on the MLA Electra 900C. Predicate Device S10K number: K974343 (Innovin)/K884863~(Electra 900C) Product Code: 81GIJS (Innovin)/81GKP (Electra 900C) CARESIDE, Inc. CARESIDE™ PT Premarket Notifica… | 1989 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 10 years and passes through 3 companies; a new generation was cleared every 9.3 years on median.
- None of the 3 ancestors has a recall.
How does its category compare?
All GJS devicesGJS Test, Time, Prothrombin: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · GJS
3in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · GJS
60in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GJS
1in 2022
Class I (5 since 2007) Class II/III not classified
Adverse event reports per year · GJS
105in 2025
MAUDE reports naming product code GJS, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 4 | 77 | 5 | 439 |
| 2008 | 1 | — | 3 | 420 |
| 2009 | 0 | — | 4 | 876 |
| 2010 | 4 | 168 | 2 | 2,177 |
| 2011 | 0 | — | 1 | 2,965 |
| 2012 | 1 | — | 1 | 2,198 |
| 2013 | 1 | — | 1 | 2,584 |
| 2014 | 1 | — | 4 (3) | 2,397 |
| 2015 | 0 | — | 0 | 1,260 |
| 2016 | 1 | — | 0 | 864 |
| 2017 | 1 | — | 5 | 532 |
| 2018 | 2 | — | 3 (2) | 1,958 |
| 2019 | 2 | — | 0 | 2,385 |
| 2020 | 1 | — | 2 | 1,390 |
| 2021 | 0 | — | 1 | 1,359 |
| 2022 | 3 | 399 | 1 | 1,210 |
| 2023 | 2 | — | 0 | 809 |
| 2024 | 1 | — | 0 | 177 |
| 2025 | 3 | 60 | 0 | 105 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
For in vitro diagnostic use with the CARESIDE Analyzer™ to measure prothrombin time from applied citrated whole blood or citrated plasma as a general screening procedure for the detection of possible clotting deficiencies in the extrinsic pathway or to monitor patients receiving anticoagulant therapy.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K991065 · printed Nov 4, 2026
Cite this page
510(k) Report. “K991065: Careside PT.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K991065
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026